New User:

Forgot your password?

Stock Market & Financial Investment News

News Breaks
January 22, 2014
07:57 EDTMELAMELA Sciences announces results of third MelaFind meeting
MELA Sciences announced the results of its third company-sponsored Clinical Advisory meeting hosted during the Winter Clinical Dermatology Conference in Hawaii where technical advancements of MelaFind and future technology development opportunities were discussed and userís validated its clinical use. Retrospective data from the MelaFind pivotal study was used to investigate the MelaFind multispectral images and classifier score result as a tool to differentiate cutaneous melanoma from other pigments skin lesions. Results showed the average classifier scores of melanomas, high-grade lesions, non-melanoma skin cancers, and histologically benign nevi were 3.5, 2.7, 2.6 and 1.6 respectively. Further results showed an increase in the mean classifier score result with each additional clinical characteristic present in the lesion.
News For MELA From The Last 14 Days
Check below for free stories on MELA the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
August 26, 2014
08:05 EDTMELAMELA Sciences and Columbia University to collaborate in MelaFind system research
Subscribe for More Information
August 20, 2014
10:44 EDTMELAMELA Sciences files to sell 21.64M shares of common stock for holders
Subscribe for More Information
August 18, 2014
10:01 EDTMELAOn The Fly: Analyst Initiation Summary
Subscribe for More Information
07:11 EDTMELAMELA Sciences initiated with a Buy at H.C. Wainwright
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the disclaimer & terms of use